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ABSTRACT 
Purpose: To review the literature on tubulointerstitial nephritis and uveitis (TINU) 
syndrome, and to report a case of a patient with relapsing polychondritis (RP) and TINU 
syndrome. 
Method: TINU syndrome is a rare oculo-renal inflammatory disorder. It is more common in 
young women with autoimmune conditions, infections, systemic disease, and previous use 
of medications. We report the case of a 62-year-old woman with relapsing polychondritis 
and a 2-year history of acute, recurrent, asymmetric, bilateral, anterior, non-
granulomatous uveitis accompanied by tubulointerstital nephritis. The patient was 
diagnosed with TINU syndrome associated with relapsing polychondritis. No cases of this 
association have been reported in the literature. The clinical features of TINU syndrome 
are discussed based on the published works. 
Conclusion: TINU is an uncommon syndrome; only about 200 cases have been reported in 
the literature related to infections, systemic disease, and previous use of medications such 
as antibiotics and non-steroidal anti-inflammatory drugs. We found that it can be 
associated with relapsing polychondritis; therefore, it is important to investigate 
symptoms of this disease since TINU syndrome can co-exist with it.  
Key Words: Acute tubulointerstitial nephritis, uveitis, nephropathy, TINU syndrome, 
relapsing polychondritis.  
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INTRODUCTION 
 
Tubulointerstitial nephritis and uveitis (TINU) or Dobrin syndrome is a rare oculo-renal 
inflammatory disorder, characterized by acute tubulointerstitial nephritis and uveitis 
without a known specific underlying systemic disease
.1
 
It can be associated with autoimmune conditions, infections, systemic disease, and 
previous use of medications.
2 
Although there are some reports of TINU syndrome in 
elderly patients, it generally occurs in children and young adults.
3
 Females are affected 
three times more often than males.
3–5
 It affects, approximately, 1–2% of the patients who 
visit uveitis clinics.
3,4 
Generally, renal involvement in TINU is mild, and uveitis tends to 
recur in some patients.
3
 
 
Genetic markers for TINU were identified by Levinson et al.
6,7
 They found that HLA-
DQA1*01, HLA-DQB1*05, and HLA-DRB1*01 were highly associated with TINU syndrome 
in their patient population, and concluded that HLA-DQA1*01/DQB1*05 may be related to 
risk of development of the disease.
6,7
 HLA analysis on patients with isolated bilateral 
sudden-onset uveitis (TINU subtype) and with isolated tubulointerstitial nephritis (TIN 
subtype) showed that HLA DRB1*0102 could be related to TINU but not to a TIN subset.
8 
Bilateral panuveitis with chorioretinal lesions in pediatric patients was found to be 
associated with the HLA-DR, DQ class II type, in TINU syndrome
.9
 
 
Mandeville determined the diagnostic criteria for TINU syndrome characterized by the 
presence of histopathologically confirmed acute interstitial nephritis (AIN) and typical 
bilateral anterior non-granulomatous uveitis.
2 
Clinical manifestations can be nonspecific 
(fever, abdominal pain, weight loss, fatigue, malaise, anorexia, and headache), and 
generally, renal involvement is mild.
3
 Signs include sterile pyuria, hematuria, and different 
states of renal failure.
1 
 
Uveitis may not become apparent for weeks to months after systemic problems have 
resolved.
1 
It may occur 2 months before the presentation of acute interstitial nephritis in 
approximately one-fifth of patients, but in most cases (65%), nephritis precedes uveitis.
2 
It 
presents as episodes of sudden onset of bilateral anterior non-granulomatous uveitis, and 
it is chronic or recurrent in about one-half of reported individuals.
1,10 
 
We present a case of a patient with relapsing polychondritis and TINU syndrome. To our 
knowledge, this is the first case of TINU syndrome associated with relapsing polychondritis 
to be reported. 
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CASE REPORT 
 
A 62-year-old female presented to the uveitis service at the Rosario University in Bogotá, 
Colombia, with a 2-year history of six acute episodes of conjunctival hyperemia, pain, and 
myodesopsia in both eyes. She reported also a long-term decrease in visual acuity and, 
systemically, fatigue, tiredness, rhinitis, cough, dry skin, tinnitus, acute sensorineural 
hearing loss, and dizziness. She had a history of relapsing polychondritis with positive 
rheumatoid factor. Previously, in another institution, she had been treated with 
azathioprine for 3 months without improvement, two doses of infliximab (this was 
suspended because of deterioration of renal function tests), systemic steroids 
(prednisolone, deflazacort), topical steroids, mydriatics, and topical cyclosporine.  
 
Laboratory testing showed elevated serum creatinine (1,51 mg/dL) and urea, elevated 
globular sedimentation velocity (23 mm/h), elevated uric acid, positive rheumatoid factor 
(80 u/mL, reference value: 40–60 u/mL), elevated β-2 microglobulin in urine, and normal 
c-reactive protein, ANAS, pANCAS, cANCAS, C3, and C4. Due to her abnormal renal 
function, she was referred to nephrology for further assessment.  Renal biopsy showed 
tubulointerstital changes, focal segmental glomerulosclerosis, and thin basement 
membrane disease compatible with TINU syndrome. 
 
This patient was diagnosed with relapsing polychondritis by a rheumatologist due to clear 
manifestations of inflammatory episodes in cartilaginous tissues such us the external ears, 
presenting inability to sleep on the affected side; episodes of painful nasal bridge, and 
laryngotracheobronchial tree symptoms consistent of chronic cough and bronchitis. In 
addition, she presented episodes of audiovestibular symptoms consistent of suddenly 
diminished hearing, tinnitus, and vertigo. At the time of consultation in our service she did 
not present signs of active polychondritis, but the external examination of her ears 
revealed the beginning of floppy ears (Figure 1). This clinical pictured is in accordance to 
the episodic nature of RP. 
Ocular examination showed best-corrected visual acuity (BCVA) 20/40 in the right eye and 
20/25 in the left eye. Pupils were round and reactive to light with no afferent pupillary 
defect in either eye. Anterior segment examination of the right eye revealed a mild degree 
of inflammatory cells in the anterior chamber (0.5+), pigment on anterior lens capsule, 
and posterior subcapsular cataract; the iris had no synechiae (Figure 2). Evaluation of the 
left eye showed pigment on the anterior lens capsule and nuclear cataract; there was no 
evidence of inflammatory cells in the anterior chamber or iris synechiae (Figure 3). 
Intraocular pressures were 12 mmHg in both eyes. Fundus examination was within normal 
limits.  
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Figure 1.Beginning of deformity of the ears as a consequence of episodic cartilage 
inflammation. 
 
 
Figure 2. Anterior segment photography of the right eye. The patient presented a mild 
degree of inflammatory cells in the anterior chamber associated with pigment on the 
anterior lens capsule and posterior subcapsular cataract.   
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Figure 3. Anterior segment photography of the left eye. There was pigment on the 
anterior lens capsule and nuclear cataract, with no evidence of inflammatory cells in the 
anterior chamber or iris synechiae. 
 
 
EPIDEMIOLOGY  
 
TINU is an uncommon syndrome, first reported and described by Dobrin in 1975.
11
 Since 
then, only about 200 cases have been reported in the literature.
2,12
 It generally occurs in 
young adults, and females are affected three times more often than males.
3,5
  
It affects, approximately, 1–2% of the patients who visit uveitis clinics 3,4 and a diagnosis of 
TINU generally only accounts for 1–2% of all patients attending specialized uveitis centres. 
12
 In Japan, TINU syndrome is the second most frequent diagnosis in children with uveitis 
after sarcoidosis and in Europe TINU syndrome has been reported in Spain, France, 
Belgium, Italy, Poland, Germany, Austria, Switzerland, the Czech Republic, the UK, Serbia, 
Croatia, and Greece.
13 
Generally, renal involvement in TINU is mild, whereas the uveitis 
tends to recur in some patients.
3 
No racial predilection has been identified.
12
 
 
It is possible that ophthalmologists are not diagnosing the disease because the physicians 
who first evaluate the patient have not considered TINU syndrome. This may be because 
the presenting symptoms can be nonspecific (fever, abdominal pain), the patient 
diagŶosed as haǀiŶg a ͞ǀiral syŶdroŵe͟ aŶd the uǀeitis ŵay Ŷot ďeĐoŵe eǀideŶt for ǁeeks 
to months after the systemic problems have resolved. By the time the patient is referred 
for consultation for the uveitis, evidence of the interstitial nephritis may be difficult to 
establish.
1
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PATHOLOGY AND PATHOGENESIS 
 
TINU is characterized by idiopathic acute tubulointerstitial nephritis and uveitis.
4
 
The pathogenesis of TINU is not clear, but it is thought to be the result of an autoimmune 
process that might involve humoral and cellular autoimmunity.
14,15
 
Reported systemic associations between tubulointerstitial nephritis and uveitis include 
Fanconi syndrome
16,17
 and bilateral optic disc edema.
11
 Additionally, there are case 
reports with no systemic associations as described by Mortajil et al.
 4
 aŶd LeśŶiak K et al.18 
 
Autoimmune diseases such as rheumatoid arthritis, hyperthyroidism, primary 
hypoparathyroidism, and Sjögren syndrome have been reported to accompany TINU 
syndrome.
13
 We found no such associations in our case.  
 
Interestingly, renal tubular and ciliary body epithelia share some similar functions, such as 
those pertaining to electrolyte transporters sensitive to carbonic anhydrase inhibitors
14.
 
Thus, it is conceivable that they might share cross-reactive autoantigens.
14,19,20
 Yin Tang et 
al.
14 
and Li et al.
21
 demonstrated for the first time a high prevalence of serum 
autoantibodies against modified C-reactive protein (anti-mCRP autoantibodies) in patients 
with TINU syndrome.
 14 
The results of Ying Tang suggest that mCRP may be one of the 
common target autoantigens in renal and ocular tissues in patients with TINU syndrome. 
Plasma C-reactive protein (CRP), a member of the pentraxin family, under certain 
conditions such as altered pH, high urea concentration, or low calcium concentration, 
dissociates irreversibly into monomers, also called modified CRP (mCRP). In this study, 
mCRP autoantibodies were screened by ELISA with purified human C-reactive protein in 
nine patients with TINU syndrome, and mCRP expression was analyzed by 
immunohistochemistry in renal biopsy specimens from the nine patients along with 40 
from disease controls. The mCRP autoantibodies were detected in all nine patients with 
TINU syndrome, significantly higher than in the disease controls. The renal histologic score 
of mCRP in TINU syndrome was significantly higher than that in disease controls. The 
staining of mCRP and human IgG were co-localized in renal and ocular tissues.
14 
These 
results suggest that mCRP may be one of the common target autoantigens in renal and 
ocular tissues in patients with TINU syndrome.
14
 In comparison with other renal diseases 
and normal controls, the high prevalence of serum anti-mCRP autoantibodies in TINU 
syndrome was impressive, especially in the active phase of nephritis.
14
 
 
Otherwise, some studies have described that renal tubulointerstitial infiltrates are 
primarily composed of activated lymphocytes, among which the helper/inducer T-cell 
subset is reported to be predominant,
22,23
 furthermore, cell-mediated immunity, in 
particular delayed-type hypersensitivity, could play a large role in TINU syndrome.
24
 Most 
of the studies describing immunohistochemical kidney analysis in TINU patients have 
demonstrated that interstitium is infiltrated mainly by T-cells together with 
monocytes/macrophages
25,26
 and the case reports of Abed et al.
22
 and others have 
described that the helper/inducer T-cell subset was predominant in renal interstitial 
infiltration in TINU.
22 
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Relapsing polychondritis is a rare autoimmune disorder characterized by episodic, 
progressive inflammatory destruction of cartilage.
27 
The exact etiology and 
physiopathology of the disease has not been established.
28 
It affects cartilaginous 
structures including ears, nose, tracheobronchial tree, and joints; it can also involve non-
cartilaginous tissues rich in proteoglycans such as the eyes, inner ear, heart, blood vessels, 
and kidney.
27,28
 Diagnostic criteria were established by Michet et al.
29
 which require the 
presence of proven inflammation in at least two of three of the auricular, nasal, or 
laryngotracheal cartilages, or proven inflammation in one of these cartilages plus two 
other signs, including ocular inflammation, vestibular dysfunction, seronegative 
inflammatory arthritis, or hearing loss.
28,29 
 
Our case is consistent with the diagnosis of TINU syndrome and was confirmed 
histopathologically with renal biopsy associated with typical bilateral uveitis. However, 
unlike previous reports, our patient had a history of relapsing polychondritis associated 
with recurrent, asymmetric, bilateral anterior non-granulomatous uveitis episodes in the 
last two years, with subsequent renal involvement consisting of tubulointerstitial nephritis 
that did not require dialysis.  
 
Uveitis was treated with topical steroids (prednisolone 1%), topical non-steroidal anti-
inflammatory (ketorolac 0.4%) and systemic steroids (deflazacort) in another institution. 
 
Eight months later the patient remained symptomatic with signs of uveitis in both eyes, 
and consulted again with our service. BCVA was 20/30 in the right eye and 20/40 in the 
left eye. Subsequently, the uveitis was treated with mycophenolate mofetil. Her renal 
function and ocular inflammation showed a steady recovery, followed by complete 
resolution of the uveitis.  In the last two years, since the beginning of treatment with 
mycophenolate mofetil, she has not had any relapses. However in the last optic coherence 
tomography taken after treatment the patient presented macular edema and epiretinal 
membrane in both eyes (Figures 4 and 5).  
 
Figure 4: Optical coherence tomography of the right eye with evidence of macular edema 
and epiretinal membrane.  
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Figure 5: Optical coherence tomography of the left eye with evidence of much marked 
macular edema and epiretinal membrane.  
 
 
RISK FACTORS AND ASSOCIATED FACTORS 
 
TINU has been linked with a hypersensitivity reaction, autoimmune conditions, infections, 
and systemic disease. It has been suggested that non-steroidal anti-inflammatory agents 
or antibiotics may precipitate TINU syndrome, but this has been difficult to establish.
2,30
 
 
Mackensen et al. reported a retrospective case series of 33 patients with TINU 
syndrome.
12
 Seven patients had been taking occasional ibuprofen within approximately 2 
to 6 weeks of the time of disease onset. Two other patients were taking other non-
steroidal anti-inflammatory drugs. Only two individuals had been taking antibiotics: one, 
erythromycin, and the other, co-trimoxazole and amoxicillin–clavulanic acid. Nevertheless, 
it was not possible to establish a causal relationship between the medication used and 
TINU syndrome in any of the patients.
12
 
On the other hand, Suzuki et al.
31
 reported a case of a 58-year-old man with fever and 
arthralgia. His clinical course and marked ciliary hyperemia allowed suspected 
tubulointestinal nephritis and uveitis (TINU) syndrome, which was confirmed 
ophthalmologically and by renal biopsy. Results of a drug-induced lymphocyte-stimulating 
test ǁere positiǀe for the ChiŶese herď ͞GoreisaŶ.͟ This ǁas the first Đase iŶ ǁhiĐh the use 
of ͞GoreisaŶ͟ ǁas Đausally related to TINU syndrome.31 
 
CLINICAL SPECTRUM 
 
General symptoms like fever (53%), weight loss (47%), general weakness and malaise 
(44%), nausea, asthenia, myalgia, headache, emesis, and anorexia (28%) may be 
presenting signs.
3
 The classic triad consists of inflammatory syndrome, nephritis, and 
uveitis.
5 
Anemia may be present, and the erythrocyte sedimentation rate may be 
markedly elevated.
1
 In our case, the patient referred with cough, dry skin, fatigue, 
tiredness, tinnitus, acute sensorineural hearing loss, and dizziness. Concomitant 
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autoimmune disease could be present in one-third of patients with RP.
32
 In our patient, 
the rheumatoid factor (RF) was slightly positive: 80 u/mL (reference value: 40–60 u/mL), 
which is not common in RP in which seronegative inflammatory arthritis is characteristic. 
Moreover, rheumatoid arthritis (RA) was ruled out, having taken into account that her 
physical and radiological evidence did not correspond to RA. In addition, anti-cyclic 
citrullinated peptide (anti-CCP) titer was negative. The presences of anti-CCP antibodies 
are typically elevated in RA but not in relapsing polychondritis. 
 
Ocular effects seen with uveitis are limited to the anterior chamber in 80% of cases; both 
eyes are affected in 77% of cases. The uveitis tends to be bilateral, anterior, and non-
granulomatous, but cases of unilateral or granulomatous uveitis and involvement of the 
intermediate or posterior segment and panuveitis have been reported.
13
 The uveitis is 
most often symptomatic, with pain and photophobia.
1
 In most cases, nephritis precedes 
uveitis, however in 21% of cases uveitis is present before nephritis and in 15%, the two 
conditions occur simultaneously.
2
 Retinal vasculitis with retinal vascular sheathing has 
been reported in two patients, intraretinal hemorrhages and exudates in three patients, 
focal chorioretinitis in two patients, and multifocal choroiditis in one patient.
1
 Symptoms 
associated with interstitial nephritis are flank pain, pyuria, hematuria, and proteinuria. 
Renal failure could occur and may be acute or/and chronic.
3
 
On slit lamp examination, fine keratic precipitates, anterior chamber cells, sometimes a 
high flare even fibrin and, rarely, a hypopyon, are seen. Posterior synechiae may have 
formed already at first presentation and the posterior segment of the eye is not involved 
except for mild vitreous cells and possibly complications of anterior uveitis as disk edema 
and/or macular edema.
12 
Also, nodular escleritis may be part of the possible spectrum of 
ocular inflammation occurring as part of the TINU syndrome as described by Ebenezer et 
al. in their case report.
33
 
On the other hand, chorioretinal lesions have rarely been described as part of the 
spectrum of TINU.
2,34
 Amro, Ali et al.
35
 reported four patients with presumed TINU and 
inferior chorioretinal scars.
35 
However, because only one of the patients had biopsy 
proven TINU, they were not able to conclude on the basis of the report alone that TINU is 
definitely associated with chorioretinal lesions.
35
 
 
DIAGNOSIS 
 
While diagnostic criteria of TINU syndrome have been published, it is important to take 
into consideration that not every patient will be diagnosed at the time of presentation, 
and not every patient will have a renal biopsy to make the diagnosis of interstitial 
nephritis, or present with the typical bilateral anterior uveitis.
1 
Once the physician 
suspects TINU syndrome according to the clinical presentation, urinalysis, including 
microscopic examination of the urinary sediment, should be included in the work-up of all 
pediatric uveitis patients. The presence of glycosuria, proteinuria, aminoaciduria, or 
microscopic hematuria necessitates evaluation by a nephrologist. Twenty-four hour urine 
collection for proteins, β-2 microglobulin, and N-acetyl-b-D-glucosaminidase aid in the 
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diagnosis. Renal biopsy demonstrates necrosis of renal tubule epithelium. Interstitial 
edema, and CD4 positive lymphocytic infiltrates are the hallmark features.
5,36
 
 
Genetic markers for TINU have been related to the risk of development of the syndrome 
and of some subsets of the disease. Some of these markers are: HLA-DRB1*01, HLA 
DRB1*0102, HLA-DQA1*01, and HLA-DQB1*05.
6–9
 
 
Definite TINU syndrome is diagnosed when acute interstitial nephritis is firmly established 
and the patient has bilateral anterior uveitis of sudden onset, which is the most common 
ocular presentation in reported cases, and well-established acute interstitial nephritis.
1
 
For definite TINU syndrome, acute interstitial nephritis is diagnosed either by histologic 
examination of renal biopsy specimens, or by all three of the following criteria for AIN: 1)
 
abnormal renal function, usually mildly elevated creatinine or creatinine clearance, 2) 
abnormal findings on urinalysis consistent with AIN, and 3) history of acute systemic 
illness lasting for at least 2 weeks, characterized by the typical signs, symptoms, and 
laboratory findings.
1
 
 
Differential diagnosis of TINU syndrome includes other causes of nephropathy and uveitis, 
suĐh as poststreptoĐoĐĐal gloŵeruloŶephritis, systeŵiĐ lupus erytheŵatous, WegeŶer’s 
granulomatosis, sarcoidosis, juvenile idiopathic arthritis, IgA nephropathy, Sjögren 
syndrome, Adamantiades-Behcet disease, syphilis, tuberculosis, brucellosis, and 
leptospirosis.
5
 
 
TREATMENT  
 
Once the diagnosis of TINU is made, immediate steroid therapy is necessary together with 
a collaborative approach to treatment by an internist and an ophthalmologist.
3
 
Tubulointerstitial nephritis can resolve spontaneously and dialysis therapy is not usually 
required.
37 
Treatment for auricular or nasal chondritis or peripheral arthritis without other 
significant organ involvement in relapsing polychondritis includes low-dose 
corticosteroids; other more severe disease manifestations may require treatment with 
high-dose corticosteroids or other immunosuppressive agents.
28
 
 
In reported cases of TINU syndrome, uveitis was chronic or recurrent in about half of the 
individuals; treatment has included the use of systemic steroids, topical steroids, and 
mydriatics. In our patient, it was important to establish systemic treatment to control not 
only tubulointerstitial nephritis and uveitis, but also underlying relapsing polychondritis 
with antimetabolites and other corticosteroid-sparing immunomodulatory agents in order 
to avoid potential complications such as cataracts, glaucoma, and macular edema.
38 
Our 
patient presented an adequate systemic response to immunomodulatory treatment with 
mycophenolate mofetil.  
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PROGNOSIS 
 
In TINU syndrome, uveitis tends to persist or relapse in 50% of patients, and is 
characterized by severe inflammation with a high prevalence of posterior segment 
involvement.
6,13 
In a retrospective case series of 1,985 patients with uveitis, individuals 
with TINU represented 1.7% of all patients with uveitis (n = 33).
12 
The course of the 
disease was persistent over a median of 7 months (range, 1–147), after which the 
inflammation resolved in five patients (15%) (1, 8, 12 and 24 months). The other 28 
patients were still active at the last follow-up or were followed up by their primary 
ophthalmologist.
12 
The beneficial effect of systemic steroids for treatment is well 
established but a relapse may occur following discontinuation of the steroids and may 
require immunosuppressive drugs because of frequent recurrences; for this reason 
immunotherapy with methotrexate, cyclosporine A, and azathioprine has been 
suggested.
39,40. 
Our patient required additional treatment, initially with azathioprine, and 
then with mycophenolate mofetil, due to relapses of anterior uveitis despite the 
treatment with systemic steroids. Our patient was treated in another institution without 
systemic therapy during for 8 months, and she had persistent inflammation, developing 
epiretinal membrane and macular edema. TINU syndrome generally has a favorable 
prognosis and renal dysfunctions tend to be self-limiting.  
 
CONCLUSION 
 
TINU syndrome is an unusual disease that has been related to a hypersensitivity reaction; 
it can be connected to autoimmune conditions, infections, systemic disease, and previous 
use of medications such as antibiotics and non-steroidal anti-inflammatory drugs.
11.  
Previous cases have not been associated with relapsing polychondritis; it is important to 
investigate the presence of symptoms of this disease since TINU syndrome can co-exist 
with it.  
 
DECLARATION OF INTEREST  
 
The authors report no conflicts of interest. The authors alone are responsible for the 
content and writing of the paper. 
 
 
 
 
 
 
 
 
 
 
 
 12 
REFERENCES 
1. Levinson, R. D. Tubulointerstitial nephritis and uveitis syndrome. Int. Ophthalmol. 
Clin. 48, 51–9 (2008). 
2. Mandeville, J. T., Levinson, R. D. & Holland, G. N. The tubulointerstitial nephritis and 
uveitis syndrome. Surv. Ophthalmol. 46, 195–208 (2001). 
3. Han, J. M., Lee, Y. J. & Woo, S. J. A case of tubulointerstitial nephritis and uveitis 
syndrome in an elderly patient. Korean J. Ophthalmol. 26, 398–401 (2012). 
4. Mortajil, F. et al. Acute tubulointerstitial nephritis and anterior uveitis (TINU 
syndrome): a report of two cases. Saudi J. Kidney Dis. Transpl. 17, 386–9 (2006). 
5. Hinkle, D. M. & Foster, C. S. Tubulointerstitial nephritis and uveitis syndrome. Int. 
Ophthalmol. Clin. 48, 9–13 (2008). 
6. Levinson, R. D. et al. Strong associations between specific HLA-DQ and HLA-DR 
alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest. Ophthalmol. 
Vis. Sci. 44, 653–7 (2003). 
7. Parameswaran, S., Mittal, N., Joshi, K. & Rathi, M. Tubulointerstitial nephritis with 
uveitis syndrome: A case report and review of literature. Indian J. Nephrol. 103–105 
(2010). 
8. Mackensen, F. et al. HLA-DRB1*0102 is associated with TINU syndrome and 
bilateral, sudden-onset anterior uveitis but not with interstitial nephritis alone. Br. 
J. Ophthalmol. 95, 971–5 (2011). 
9. Reddy, A. K., Hwang, Y.-S., Mandelcorn, E. D. & Davis, J. L. HLA-DR, DQ class II DNA 
typing in pediatric panuveitis and tubulointerstitial nephritis and uveitis. Am. J. 
Ophthalmol. 157, 678–86.e1–2 (2014). 
10. Mackensen, F., Smith, J. R. & Rosenbaum, J. T. Enhanced recognition, treatment, 
and prognosis of tubulointerstitial nephritis and uveitis syndrome. Ophthalmology 
114, 995–9 (2007). 
11. Menezo, V. & Ram, R. Tubulo-interstitial nephritis and uveitis with bilateral optic 
disc oedema. Eye (Lond). 18, 536–7 (2004). 
12. Mackensen, F. & Billing, H. Tubulointerstitial nephritis and uveitis syndrome. Curr. 
Opin. Ophthalmol. 20, 525–31 (2009). 
 13 
13. Thomassen, V. H., Ring, T., Thaarup, J. & Baggesen, K. Tubulointerstitial nephritis 
and uveitis (TINU) syndrome: a case report and review of the literature. Acta 
Ophthalmol. 87, 676–9 (2009). 
14. Tan, Y. et al. Modified C-reactive protein might be a target autoantigen of TINU 
syndrome. Clin. J. Am. Soc. Nephrol. 6, 93–100 (2011). 
15. Gafter, U. et al. Tubulointerstitial nephritis and uveitis: association with suppressed 
cellular immunity. Nephrol. Dial. Transplant 8, 821–6 (1993). 
16. Llorente-Gómez, B., González-Menchén, C. & de Lucas-Collantes, C. Tubulo-
interstitial nephritis and uveitis with Fanconi syndrome. Nefrologia 32, 263–4 
(2012). 
17. Koike, K. et al. Adult-onset acute tubulointerstitial nephritis and uveitis with 
Fanconi syndrome. Case report and review of the literature. Clin. Nephrol. 67, 255–
9 (2007). 
18. LeśŶiak, K., Kade, G. & NieŵĐzyk, “. [AĐute reŶal iŶjury iŶ the Đourse of reŶal-ocular 
syndrome - case report]. Pol. Merkur. Lekarski 34, 37–9 (2013). 
19. Izzedine, H. Tubulointerstitial nephritis and uveitis syndrome (TINU): a step forward 
to understanding an elusive oculorenal syndrome. Nephrol. Dial. Transplant 23, 
1095–7 (2008). 
20. Sugimoto, T. et al. Is tubulointerstitial nephritis and uveitis syndrome associated 
with IgG4-related systemic disease? Nephrology (Carlton). 13, 89 (2008). 
21. Li, C., Su, T., Chu, R., Li, X. & Yang, L. Tubulointerstitial nephritis with uveitis in 
Chinese adults. Clin. J. Am. Soc. Nephrol. 9, 21–8 (2014). 
22. Abed, L. et al. Presence of autoantibodies against tubular and uveal cells in a 
patient with tubulointerstitial nephritis and uveitis (TINU) syndrome. Nephrol. Dial. 
Transplant 23, 1452–5 (2008). 
23. Tanaka, H. et al. Repeat renal biopsy in a girl with tubulointerstitial nephritis and 
uveitis syndrome. Pediatr. Nephrol. 16, 885–7 (2001). 
24. Yoshioka, K., Takemura, T., Kanasaki, M., Akano, N. & Maki, S. Acute interstitial 
nephritis and uveitis syndrome: activated immune cell infiltration in the kidney. 
Pediatr. Nephrol. 5, 232–4 (1991). 
25. Takemura, T. et al. Course and outcome of tubulointerstitial nephritis and uveitis 
syndrome. Am. J. Kidney Dis. 34, 1016–21 (1999). 
 14 
26. Kobayashi, Y., Honda, M., Yoshikawa, N. & Ito, H. Immunohistological study in 
sixteen children with acute tubulointerstitial nephritis. Clin. Nephrol. 50, 14–20 
(1998). 
27. Chopra, R., Chaudhary, N. & Kay, J. Relapsing polychondritis. Rheum. Dis. Clin. North 
Am. 39, 263–76 (2013). 
28. Arnaud, L., Mathian, A., Haroche, J., Gorochov, G. & Amoura, Z. Pathogenesis of 
relapsing polychondritis: a 2013 update. Autoimmun. Rev. 13, 90–5 (2014). 
29. MiĐhet, C. J., MĐKeŶŶa, C. H., Luthra, H. “. & O’FalloŶ, W. M. RelapsiŶg 
polychondritis. Survival and predictive role of early disease manifestations. Ann. 
Intern. Med. 104, 74–8 (1986). 
30. Fried, T. Acute interstitial nephritis. Why do the kidneys suddenly fail? Postgrad. 
Med. 93, 105–6, 111–2, 117–20 (1993). 
31. Suzuki, H. et al. Tubulointerstitial nephritis and uveitis (TINU) syndrome caused by 
the ChiŶese herď ͞GoreisaŶ͟. Clin. Exp. Nephrol. 13, 73–6 (2009). 
32. Puéchal, X. et al. Relapsing polychondritis. Joint. Bone. Spine 81, 118–24 (2014). 
33. Daniel, E., Gangaputra, S., Kempen, J. H. & Jabs, D. a. Recurrent nodular scleritis 
preceding an adult TINU syndrome. Ocul. Immunol. Inflamm. 14, 239–40 (2006). 
34. Derzko-Dzulynsky, L. & Rabinovitch, T. Tubulointerstitial nephritis and uveitis with 
bilateral multifocal choroiditis. Am. J. Ophthalmol. 129, 807–9 (2000). 
35. Ali, A. & Rosenbaum, J. T. TINU (tubulointerstitial nephritis uveitis) can be 
associated with chorioretinal scars. Ocul. Immunol. Inflamm. 22, 213–7 (2014). 
36. Helms, E. et al. Tubulointerstitial nephritis and uveitis syndrome: use of gallium 
scintigraphy in its diagnosis and treatment. Int. Urol. Nephrol. 37, 119–22 (2005). 
37. Savaj, S. & Asgari, M. Kidney diseases Tubulointerstitial Nephritis and Uveitis. Iran. 
J. Kidney Dis. 5, 66–69 (2011). 
38. Gion, N., Stavrou, P. & Foster, C. S. Immunomodulatory therapy for chronic 
tubulointerstitial nephritis-associated uveitis. Am. J. Ophthalmol. 129, 764–8 
(2000). 
39. Weinstein, O. et al. Clinical manifestations of adult tubulointerstitial nephritis and 
uveitis (TINU) syndrome. Int. Ophthalmol. 30, 621–8 (2010). 
 15 
40. Taheri, S. & Taheri, D. Short course of cyclophosphamide therapy may reduce 
recurrence in patients with tubulointerstitial nephritis and uveitis syndrome. Saudi 
J. Kidney Dis. Transplant. 20, 655–657 (2009).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
